Security key
720795103
- Security type / class
- Equity / COM
- Total 13F shares
- 48,596,995
- Total 13F value
- $8,041,768
- Share change
- +14,392,994
- Put/Call ratio
- 3.7%
- SEC-reported price per share
- $0.17
- Number of holders
- 44
- Value change
- -$5,167,205
- Number of buys
- 12
- Number of sells
- 34
Open additional details 1 more signal available
Report period
Q2 2023
Institutions
44
Top holders
10
PIRS full security history
Ownership snapshot
Full 13F holder table
PALVELLA THERAPEUTICS, INC. SEC filings
PALVELLA THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of PIRS - PIERIS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F
Highest disclosed value: $6,898,093
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP has the largest disclosed position value at $6.9M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Disclosed position value
Top 5
Lynx1 Capital Management LP
$6.9M
BVF INC/IL
$4.96M
Aquilo Capital Management, LLC
$4.44M
Soleus Capital Management, L.P.
$4.04M
MARSHALL WACE, LLP
$2.22M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
Company
|
—
denominator unverified
|
$6,898,093
7,067,718 shares
|
— | 31 Mar 2023 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$4,958,392
5,080,320 shares
|
— | 31 Mar 2023 |
| Aquilo Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$4,443,607
4,552,876 shares
|
— | 31 Mar 2023 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$4,035,631
4,134,868 shares
|
— | 31 Mar 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$2,221,022
2,266,350 shares
|
— | 31 Mar 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$1,951,909
1,999,907 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
48,596,995
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
60
Q2 2023 holders
44
Holder diff
-16
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|